News Releases

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

September 7, 2021

Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy

August 30, 2021

Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant

August 25, 2021

Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative

August 23, 2021

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

August 18, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

May 26, 2021

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

May 20, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

May 7, 2021

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

April 19, 2021

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

April 5, 2021

Latest News & Events

Jun 3, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Read More...

Jun 2, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Read More...

May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Read More...